UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 248

Sortiert nach

Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM‐associated syndromes

American journal of medical genetics. Part A, 2023-07, Vol.191 (7), p.1826-1835

2023

Link zum Volltext

Verfügbarkeit prüfen

Global perspectives on cellular therapy for children with sickle cell disease

Current opinion in hematology, 2022-11, Vol.29 (6), p.275

2022

Link zum Volltext

Verfügbarkeit prüfen

Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2797-2803

2021

Link zum Volltext

Verfügbarkeit prüfen

Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee

Cytotherapy (Oxford, England), 2024-07, Vol.26 (7), p.660-671

2024

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab

Pediatric hematology and oncology, 2024-05, Vol.41 (4), p.260-272

2024

Link zum Volltext

Verfügbarkeit prüfen

Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma

Bone marrow transplantation (Basingstoke), 2022-04, Vol.57 (4), p.579-585

2022

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma

Pediatric transplantation, 2018-08, Vol.22 (5), p.e13210-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?

Journal of adolescent and young adult oncology, 2016-09, Vol.5 (3), p.226

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Blood advances, 2019-07, Vol.3 (14), p.2057-2068

2019

Link zum Volltext

Verfügbarkeit prüfen

Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease

The Lancet. Haematology, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant

Blood, 2019-11, Vol.134 (Supplement_1), p.996-996

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era

Blood, 2019-11, Vol.134 (Supplement_1), p.2056-2056

2019

Link zum Volltext

Verfügbarkeit prüfen

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment

Blood, 2018-11, Vol.132 (Supplement 1), p.2086-2086

2018

Link zum Volltext

Verfügbarkeit prüfen

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Blood, 2018-11, Vol.132 (Supplement 1), p.2260-2260

2018

Link zum Volltext

Verfügbarkeit prüfen

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S226-S227

2015

Link zum Volltext

Verfügbarkeit prüfen

Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population

The American journal of cardiology, 2010-10, Vol.106 (7), p.963-968

2010

Link zum Volltext

Verfügbarkeit prüfen

Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells

Nature communications, 2021-06, Vol.12 (1), p.3862-3862, Article 3862

2021

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score

Heart rhythm, 2013-09, Vol.10 (9), p.1272-1277

2013

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

Heart rhythm, 2010-04, Vol.7 (4), p.433-437

2010

Link zum Volltext

Verfügbarkeit prüfen

Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia

Heart rhythm, 2014-12, Vol.11 (12), p.2206-2213

2014

Link zum Volltext

Verfügbarkeit prüfen

A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)

Circulation (New York, N.Y.), 2012-04, Vol.125 (16), p.1997-2005

2012

Link zum Volltext

Verfügbarkeit prüfen

The impact of risk score (CHADS2 versus CHA2 DS2 -VASc ) on long-term outcomes after atrial fibrillation ablation

Heart rhythm, 2015-04, Vol.12 (4), p.681-686

2015

Link zum Volltext

Verfügbarkeit prüfen

Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?

Journal of the American College of Cardiology, 2005-05, Vol.45 (10), p.1638-1643

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(230)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM‐associated syndromes

Global perspectives on cellular therapy for children with sickle cell disease

Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience

Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee

Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab

Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma

Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma

Cognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease

Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population

Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia

A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)

The impact of risk score (CHADS2 versus CHA2 DS2 -VASc ) on long-term outcomes after atrial fibrillation ablation

Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?

Suchergebnisse filtern